BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Takahiro Nishida, Hiroaki Kataoka. Glypican 3-Targeted Therapy in Hepatocellular CarcinomaCancers 2019; 11(9): 1339 doi: 10.3390/cancers11091339
2
Pandjassarame Kangueane, Kumar Viswapoorani, Christina Nilofer, Subramani Manimegalai, Murugan Sivagamy, Uma Kangueane, Gopichandran Sowmya, Meena Kishore Sakharkar. Global Virology II - HIV and NeuroAIDS2017; : 925 doi: 10.1007/978-1-4939-7290-6_35
3
Bryan D. Fleming, Mitchell Ho. Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An UpdateBiomolecules 2020; 10(6): 934 doi: 10.3390/biom10060934
4
Amisha Singh, Ryan J. Beechinor, Jasmine C. Huynh, Daneng Li, Farshid Dayyani, Jennifer B. Valerin, Andrew Hendifar, Jun Gong, May Cho. Immunotherapy Updates in Advanced Hepatocellular CarcinomaCancers 2021; 13(9): 2164 doi: 10.3390/cancers13092164
5
Wei Cheng, Po-Chun Huang, Hsiao-Mei Chao, Yung-Ming Jeng, Hey-Chi Hsu, Hung-Wei Pan, Wuh-Liang Hwu, Yu-May Lee. Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10Oncotarget 2017; 8(46): 80429 doi: 10.18632/oncotarget.19035
6
Wei Dai, Jian Wu, Shuyan Zhang, Bingjie Shi, Xinhui Xu, Danyang Wang, Jinke Wang. Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2The International Journal of Biochemistry & Cell Biology 2017; 89: 157 doi: 10.1016/j.biocel.2017.05.031
7
Dongsheng Gu, Yongsheng Xie, Jingwei Wei, Wencui Li, Zhaoxiang Ye, Zhongyuan Zhu, Jie Tian, Xubin Li. MRI‐Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3‐Positive Hepatocellular CarcinomaJournal of Magnetic Resonance Imaging 2020; 52(6): 1679 doi: 10.1002/jmri.27199
8
Bryan Fleming, Mitchell Ho. Glypican-3 Targeting Immunotoxins for the Treatment of Liver CancerToxins 2016; 8(10): 274 doi: 10.3390/toxins8100274
9
UEG Week 2018 Oral PresentationsUnited European Gastroenterology Journal 2018; 6(S8) doi: 10.1177/2050640618792817
10
Mariela Montaño-Samaniego, Diana M. Bravo-Estupiñan, Oscar Méndez-Guerrero, Ernesto Alarcón-Hernández, Miguel Ibáñez-Hernández. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific PromotersFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.605380
11
Fubo Zhou, Wenting Shang, Xiaoling Yu, Jie Tian. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatmentMedicinal Research Reviews 2018; 38(2): 741 doi: 10.1002/med.21455
12
Rahul Agarwal, Jitendra Narayan, Amitava Bhattacharyya, Mayank Saraswat, Anil Kumar Tomar. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targetsCancer Genetics 2017; : 37 doi: 10.1016/j.cancergen.2017.06.002
13
Yanli Liu, Jiaye Zhang, Yan Chen, Hasan Sohel, Xinrong Ke, Jingqi Chen, Yin-Xiong Li. The correlation and role analysis of COL4A1 and COL4A2 in hepatocarcinogenesisAging 2020; 12(1): 204 doi: 10.18632/aging.102610
14
Guangna Liu, Wei Rui, Hongli Zheng, Daosheng Huang, Fei Yu, Yuewei Zhang, Jiahong Dong, Xueqiang Zhao, Xin Lin. CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinomaEuropean Journal of Immunology 2020; 50(5): 712 doi: 10.1002/eji.201948457
15
Naihan Han, Wenshuang Wang, Danrong Lu, Han Wang, Xinying Ma, Xiaopeng Fan, Fuchuan Li. A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinomaChemical Communications 2017; 53(90): 12209 doi: 10.1039/C7CC06305A
16
Mauro Montalbano, Giuseppe Curcurù, Ali Shirafkan, Renza Vento, Cristiana Rastellini, Luca Cicalese, Francesco Cappello. Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma LesionPLOS ONE 2016; 11(4): e0153613 doi: 10.1371/journal.pone.0153613
17
Arvindhan Nagarajan, Parmanand Malvi, Narendra Wajapeyee. Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and ProgressionFrontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00483
18
Sai Arun Batra, Purva Rathi, Linjie Guo, Amy N. Courtney, Julien Fleurence, Julien Balzeau, Rahamthulla S. Shaik, Thao P. Nguyen, Meng-Fen Wu, Shaun Bulsara, Maksim Mamonkin, Leonid S. Metelitsa, Andras Heczey. Glypican-3–Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular CarcinomaCancer Immunology Research 2020; 8(3): 309 doi: 10.1158/2326-6066.CIR-19-0293
19
Daša Lipovšek, Irvith Carvajal, Alban J Allentoff, Anthony Barros, John Brailsford, Qiang Cong, Pete Cotter, Sanjeev Gangwar, Cris Hollander, Virginie Lafont, Wai Leung Lau, Wenying Li, Miguel Moreta, Steven O’Neil, Jason Pinckney, Michael J Smith, Julie Su, Christina Terragni, Michael A Wallace, Lifei Wang, Martin Wright, H Nicholas Marsh, James W Bryson. Adnectin–drug conjugates for Glypican-3-specific delivery of a cytotoxic payload to tumorsProtein Engineering, Design and Selection 2018; 31(5): 159 doi: 10.1093/protein/gzy013
20
Ahmad Saad, Benjamin Liet, Gilles Joucla, Xavier Santarelli, Justine Charpentier, Stéphane Claverol, Christophe F. Grosset, Véronique Trézéguet. Role of Glycanation and Convertase Maturation of Soluble Glypican-3 in Inhibiting Proliferation of Hepatocellular Carcinoma CellsBiochemistry 2018; 57(7): 1201 doi: 10.1021/acs.biochem.7b01208
21
Cristian Turato, Anna Balasso, Vinicio Carloni, Claudio Tiribelli, Francesca Mastrotto, Antonio Mazzocca, Patrizia Pontisso. New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinomaJournal of Controlled Release 2017; 268: 184 doi: 10.1016/j.jconrel.2017.10.027
22
Yun Zhang, Jing Zhao, Jing Cai, Jia-Cong Ye, Yi-Tai Xiao, Yan Mei, Mu-Sheng Zeng, Chuan-Miao Xie, Yong Jiang, Guo-Kai Feng. Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in MiceMolecular Imaging and Biology 2020; 22(4): 864 doi: 10.1007/s11307-019-01437-z
23
John R Couchman, Hinke Multhaupt, Ralph D. Sanderson. Recent Insights into Cell Surface Heparan Sulphate Proteoglycans and CancerF1000Research 2016; 5: 1541 doi: 10.12688/f1000research.8543.1
24
Mahmoud M. A. Elsayed, Tarek M. Okda, Gamal M. K. Atwa, Gamal A. Omran, Atef E. Abd Elbaky, Abd El hakim Ramadan. Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular CarcinomaPharmaceutics 2021; 13(5): 648 doi: 10.3390/pharmaceutics13050648
25
Kui Chen, Andre Gorgen, Avrilynn Ding, Lulu Du, Keruo Jiang, Yu Ding, Gonzalo Sapisochin, Anand Ghanekar. Dual‐Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular CarcinomaHepatology Communications 2021;  doi: 10.1002/hep4.1701
26
Xiaoyu Liu, Fang Gao, Longwei Jiang, Meng Jia, Lei Ao, Ming Lu, Liming Gou, Mitchell Ho, Shaochang Jia, Fei Chen, Wei Gao. 32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinomaJournal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02462-1
27
Daniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, Matthias Ocker. Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targetsWorld Journal of Gastroenterology 2019; 25(25): 3136-3150 doi: 10.3748/wjg.v25.i25.3136
28
Yongdong Zhang, Dongri Qiu, Ronghua Li, Yawu Liu, Shuainan Shi, Yuliang Wang. Preparation of a monoclonal antibody against the carcinoembryonic antigen, glypican‑3Molecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10019
29
Samuel Achilefu, Ramesh Raghavachari, Qi Zhang, Zhihao Han, Wancun Zhang, Zhiyu Qian, Yueqing Gu. In vivo imaging of hepatocellular carcinoma using a glypican-3-binding peptide based probe Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications IX 2017; 10079: 100790T doi: 10.1117/12.2251310
30
Kévin Ly, Rachid Essalmani, Roxane Desjardins, Nabil G. Seidah, Robert Day. An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma CellsJournal of Biological Chemistry 2016; 291(47): 24676 doi: 10.1074/jbc.M116.746883
31
Liang-Chun Yin, Zhen-Chao Luo, Yan-Xin Gao, Yang Li, Qing Peng, Yi Gao. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and PrognosesBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3789613
32
Sylvie Ricard-Blum, Sylvain D. Vallet. Fragments generated upon extracellular matrix remodeling: Biological regulators and potential drugsMatrix Biology 2019; : 170 doi: 10.1016/j.matbio.2017.11.005
33
Monica Mossenta, Davide Busato, Michele Dal Bo, Giuseppe Toffoli. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic StrategiesCancers 2020; 12(6): 1668 doi: 10.3390/cancers12061668
34
Lijie Xia, Qiao Teng, Qi Chen, Fuchun Zhang. <p>Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma</p>International Journal of Nanomedicine 2020; : 2197 doi: 10.2147/IJN.S235058
35
Naofumi Mukaida, Yasunari Nakamoto. Emergence of immunotherapy as a novel way to treat hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(17): 1839-1858 doi: 10.3748/wjg.v24.i17.1839
36
Qi Zhang, Zhihao Han, Ji Tao, Menglu Zhao, Wancun Zhang, Ping Li, Liping Tang, Yueqing Gu. An innovative peptide with high affinity to GPC3 for hepatocellular carcinoma diagnosisBiomaterials Science 2019; 7(1): 159 doi: 10.1039/C8BM01016A
37
Xuan Liu, Jianyun Wen, Honglei Yi, Xiaorui Hou, Yue Yin, Guofu Ye, Xuedong Wu, Xiaotao Jiang. Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine releaseTherapeutic Advances in Medical Oncology 2020; 12: 175883592091034 doi: 10.1177/1758835920910347
38
Chunmei Xie, Christian Tiede, Xuanyi Zhang, Congrong Wang, Zhixiong Li, Xiao Xu, Michael J. McPherson, Darren C. Tomlinson, Weiwen Xu. Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10083-w
39
Fatemeh Motamedi Dehbarez, Navid Nezafat, Shirin Mahmoodi. In Silico Design of a Novel Multi-Epitope Peptide Vaccine Against Hepatocellular CarcinomaLetters in Drug Design & Discovery 2020; 17(9): 1164 doi: 10.2174/1570180817999200502030038
40
Xiuzhi Zhang, Chunyan Kang, Ningning Li, Xiaoli Liu, Jinzhong Zhang, Fenglan Gao, Liping Dai. Identification of special key genes for alcohol-related hepatocellular carcinoma through bioinformatic analysisPeerJ 2019; 7: e6375 doi: 10.7717/peerj.6375
41
Pei Wang, Wenxia Qin, Tao Liu, Duqing Jiang, Lianzhen Cui, Xiangzhen Liu, Yuan Fang, Xi Tang, Huajun Jin, Qijun Qian. PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinomaImmunobiology 2020; 225(1): 151850 doi: 10.1016/j.imbio.2019.09.009
42
Bijay Dhungel, Slawomir Andrzejewski, Aparna Jayachandran, Ritu Shrestha, Charmaine A. Ramlogan-Steel, Christopher J. Layton, Jason C. Steel. Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinomaGene Therapy 2018; 25(2): 115 doi: 10.1038/s41434-018-0002-2
43
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsOncotarget 2017; 8(8): 14192 doi: 10.18632/oncotarget.13929
44
Wafa S. Alansari, Areej A. Eskandrani. The Anticarcinogenic Effect of the Apple Polyphenol Phloretin in an Experimental Rat Model of Hepatocellular CarcinomaArabian Journal for Science and Engineering 2020; 45(6): 4589 doi: 10.1007/s13369-020-04478-7
45
Marco Di Paola, Alessandra Quarta, Francesco Conversano, Enzo Antonio Sbenaglia, Simona Bettini, Ludovico Valli, Giuseppe Gigli, Sergio Casciaro. Human Hepatocarcinoma Cell Targeting by Glypican-3 Ligand Peptide Functionalized Silica Nanoparticles: Implications for Ultrasound Molecular ImagingLangmuir 2017; 33(18): 4490 doi: 10.1021/acs.langmuir.7b00327
46
Ying Liu, Shengmeng Di, Bizhi Shi, Honghong Zhang, Yi Wang, Xiuqi Wu, Hong Luo, Huamao Wang, Zonghai Li, Hua Jiang. Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular CarcinomaThe Journal of Immunology 2019; 203(1): 198 doi: 10.4049/jimmunol.1800033
47
Meghan M. Bell, Nicholas T. Gutsche, A. Paden King, Kwamena E. Baidoo, Olivia J. Kelada, Peter L. Choyke, Freddy E. Escorcia. Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular CarcinomaMolecules 2020; 26(1): 4 doi: 10.3390/molecules26010004
48
Jia Duo, Camelia Chiriac, Richard Y.-C. Huang, John Mehl, Guodong Chen, Adrienne Tymiak, Peter Sabbatini, Renuka Pillutla, Yan Zhang. Slow Off-Rate Modified Aptamer (SOMAmer) as a Novel Reagent in Immunoassay Development for Accurate Soluble Glypican-3 Quantification in Clinical SamplesAnalytical Chemistry 2018; 90(8): 5162 doi: 10.1021/acs.analchem.7b05277
49
Sheng Yu, Zhenfeng Li, Jingzhang Li, Shimei Zhao, Shanguang Wu, Hongjing Liu, Xiongjie Bi, Dongyang Li, Jiexian Dong, Siliang Duan, Bruce D. Hammock. Generation of dual functional nanobody-nanoluciferase fusion and its potential in bioluminescence enzyme immunoassay for trace glypican-3 in serumSensors and Actuators B: Chemical 2021; 336: 129717 doi: 10.1016/j.snb.2021.129717
50
Andrew D. Ludwig, Kevin P. Labadie, Y. David Seo, Donald K. Hamlin, Holly M. Nguyen, Vimukta M. Mahadev, Raymond S. Yeung, D. S. Wilbur, James O. Park. Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular CarcinomaJournal of Oncology 2019; 2019: 1 doi: 10.1155/2019/4564707